Your browser doesn't support javascript.
loading
A framework for the development of effective anti-metastatic agents.
Anderson, Robin L; Balasas, Theo; Callaghan, Juliana; Coombes, R Charles; Evans, Jeff; Hall, Jacqueline A; Kinrade, Sally; Jones, David; Jones, Paul S; Jones, Rob; Marshall, John F; Panico, Maria Beatrice; Shaw, Jacqui A; Steeg, Patricia S; Sullivan, Mark; Tong, Warwick; Westwell, Andrew D; Ritchie, James W A.
Afiliação
  • Anderson RL; Translational Breast Cancer Program, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • Balasas T; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
  • Callaghan J; Cancer Therapeutics Cooperative Research Centre (CTx), Melbourne, Victoria, Australia.
  • Coombes RC; Commercial Partnerships, Cancer Research UK (CRUK), London, UK.
  • Evans J; Research and Innovation Services, University of Portsmouth, Portsmouth, Hampshire, UK.
  • Hall JA; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Kinrade S; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK.
  • Jones D; Research and Development, Vivacitv Ltd, Chesham, Buckinghamshire, UK.
  • Jones PS; Cancer Therapeutics Cooperative Research Centre (CTx), Melbourne, Victoria, Australia.
  • Jones R; Medicines Development for Global Health, Southbank, Victoria, Australia.
  • Marshall JF; Medicines and Healthcare Products Regulatory Agency, London, UK.
  • Panico MB; Centre for Drug Development, CRUK, London, UK.
  • Shaw JA; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK.
  • Steeg PS; Queen Mary University of London, Barts Cancer Institute, London, UK.
  • Sullivan M; Medicines and Healthcare Products Regulatory Agency, London, UK.
  • Tong W; Leicester Cancer Research Centre, University of Leicester, Leicester, Leicestershire, UK.
  • Westwell AD; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Ritchie JWA; Cancer Therapeutics Cooperative Research Centre (CTx), Melbourne, Victoria, Australia.
Nat Rev Clin Oncol ; 16(3): 185-204, 2019 03.
Article em En | MEDLINE | ID: mdl-30514977
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Metástase Neoplásica / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Revista: Nat Rev Clin Oncol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenvolvimento de Medicamentos / Metástase Neoplásica / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Revista: Nat Rev Clin Oncol Ano de publicação: 2019 Tipo de documento: Article